FFundraiseJet
BlueYard Capital logo

BlueYard Capital

Berlin, Germany · Invests in Europe; Global · Website

Check size

$500K-$5M

+ Save to my list
Pre-SeedSeedSeries AB2B SaaSAI & Machine LearningDeveloper ToolsCybersecurityHealthcare & BiotechCrypto & Web3Developer Tools & InfrastructureEnterprise SoftwareSemiconductors & HardwareBiotech & Life SciencesAerospace & DefenseSecurity & CybersecurityRobotics & AutomationClimate & Clean Energy

Thesis

Invest in only two kinds of technologies: those that move humanity toward utopia, and those that hold the line against oblivion. Back n-of-1 visions for an era of Black Swans—unconventional companies solving civilization-scale problems that others dismiss as too early, too risky, or too misunderstood.

Likely not a fit for

Templates, conventional wisdom, already-obvious startups, buffet of crowded market bets. Do not invest in founders fitting established playbooks.

How they invest

Lead or follow
Usually leads
Typical decision
~2 months
Warm intro
Not required
Involvement
Takes a board seat
Fund status
Actively deploying
Decision process
Partnership vote

Partners & team

11 contacts on file

JW

Jason Whitmire

Partner · Primary contact

MW

Michael Wax

Partner

CF

Chad Fowler

General Partner

CO

Ciarán O'Leary

General Partner

DB

David Byrd

General Partner

MW

Mike Wax

General Partner

TR

Tim Robinson

Partner

AS

Alejo Salles

Partner

PR

Peter Read

Partner

PB

Philipp Banhardt

Partner

TM

Trent McConaghy

Operating Partner

Portfolio

Number0
Ink & SwitchEnterprise Software

An independent research lab exploring the future of tools for thought, focusing on enhancing human intelligence through innovative software solutions.

CastelionAerospace Defense

Castelion designs, tests, and manufactures next-generation military systems rapidly and at massive scale to deter future wars.

Bit BioBiotech Life Sciences

Bit Bio specializes in synthetic biology for human health, focusing on the development of engineered human cells for research and therapeutic applications.

Marvel FusionClimate Clean Energy

Marvel Fusion is pioneering laser-driven fusion technology to provide clean, abundant energy without long-lived radioactive waste, aiming to commission the first commercial fusion power plant by the mid-2030s.

FlashbotsDeveloper Tools Infra

Flashbots is a research and development organization formed to mitigate the negative externalities posed by Maximal Extractable Value (MEV) to stateful blockchains, starting with Ethereum.

FilecoinDeveloper Tools Infra

Filecoin is a decentralized storage network designed to store humanity’s most important information. It operates as an open-source cloud storage marketplace, protocol, and incentive layer.

Protocol LabsEnterprise Software

Protocol Labs is an innovation network that connects over 600 tech startups, service providers, investment funds, accelerators, foundations, and other organizations developing breakthrough technologies and products in the frontiers of computing: web3, AI, AR, VR, BCI, hardware, and more.

GroqEnterprise Software

Groq is the AI inference platform delivering low cost, high performance without compromise. Its custom LPU and cloud infrastructure run today’s most powerful AI models instantly and reliably.

IonQEnterprise Software

IonQ is a leader in quantum computing, developing trapped-ion quantum computers designed to solve complex problems across various industries, including chemistry, medicine, and finance.

PrivyFintech Payments

Privy provides wallet infrastructure designed for scalability, enabling developers to create secure, programmable wallets with features like key management, user onboarding, and transaction automation.

ChemifyBiotech Life Sciences

Chemify is a chem-tech pioneer fusing chemistry, AI, and robotics to digitize and automate the discovery and synthesis of molecules. Founded in 2022, it utilizes a universal chemical programming language called Chemputation to transform digital code into real molecules.

Recent activity

BlueYard Capital in the news

Similar firms

Research briefRead more
BlueYard Capital Research Investment Thesis BlueYard Capital is a technology pragmatist venture fund investing in only two kinds of technologies: those that move humanity toward utopia, and those that hold the line against oblivion. Founded in 2016 and headquartered in Berlin, Germany, the firm invests in "n-of-1 visions for an era of Black Swans"—unconventional companies addressing civilization-scale problems that others dismiss as too early, too risky, or too misunderstood. The fund's philosophy explicitly rejects the venture industry's "buffet of already-obvious startups." Instead, BlueYard specializes in getting there early with capital in spaces the broader investment community hesitates: crypto infrastructure (2016, when it was synonymous with crime), AI chips (2018, before transformers), and defense (2023, post-Ukraine, backing hypersonic missile systems). Their thesis is deceivingly simple: they back technical founders working on hard problems that seem radioactive or deeply misunderstood to others. Stage and Check Size BlueYard invests primarily at pre-seed and seed stages : Pre-seed: $250K–$500K range for early-stage teams Seed: $1M–$5M+ for companies with working technology and initial validation Series A & Follow-ons: Selective participation in later rounds to support portfolio companies reaching critical milestones Typical initial check size ranges from $500K–$5M , with willingness to follow large rounds when portfolio companies gain traction. The fund maintains significant follow-on reserves and actively doubles down on successful bets. Lead Tendency BlueYard exhibits a strong lead tendency with frequent co-leads. Often leads seed and early Series A rounds, frequently co-leads with other early-stage investors, and is willing to back contrarian positions others avoid, often being first institutional investor in misunderstood spaces. Recent Activity (2025) BlueYard's 2025 was exceptionally active, with portfolio companies raising over $1B in follow-on capital: Major Milestone Rounds: Castelion (hypersonic defense): $100M Series A + $350M Series B Marvel Fusion (fusion energy): $120M Series B + $150M DOE project financing Chemify (compute-chemistry): $60M Series B Corintis (microfluidic cooling): $50M Series A+ Privy (decentralized identity): Acquired by Stripe at scale (100M+ accounts) New Portfolio Additions (2025): Added 13 new companies including: Aerska, Alterego, Boundless, CHOMP, Dost, Eigenblue, Foresight Data Machines, ManexAI, Miren, Number0, and ZeroPhase. Fund Performance: BlueYard's €111M debut fund posted 76% gross IRR and 3.4× DPI, driven by early bets in crypto, AI, and defense. Investment Focus Areas Computation & Intelligence Applied computation fueling breakthroughs in safe, stable, prosperous futures. Fabric-layer applications most people won't see or know about. Pattern: Early bets in AI chips, quantum computing, and cryptographic infrastructure when others dismissed them. Engineering, Aerospace & Defense Solutions to hypermodern challenges facing humanity. Defense modernization and resilient democratic societies. Pattern: Willing to back defense at scale when others avoid the space. Biology & Chemistry Foundational bio and chemical technologies unlocking longer, healthier human lifespan. Preparation for threats we can't yet see. Pattern: Early bets in programmable biology and molecular innovation. Crypto & Web3 Futuristic capital coordination systems: open, resilient, frictionless. Pattern: Early conviction in decentralized infrastructure, DeFi, and crypto rails; willing to invest during winter and when space is "radioactive". Fund Structure & Team General Partners: Chad Fowler, Ciarán O'Leary, David Byrd, Mike Wax (joined 2025, ex-Forto founder/CEO) Partners: Jason Whitmire, Tim Robinson, Alejo Salles, Peter Read, Philipp Banhardt Notable advisor: Trent McConaghy (Protocol Labs co-founder), indicating deep conviction in decentralized infrastructure. Geographic Focus Primary: Berlin, Germany (headquarters) with broader European focus. Secondary: European cities (London, major hubs). Global: Selective global exposure with particular conviction in Europe-based technical founders solving civilization-scale problems. Decision Process Partnership-based with deep technical diligence. Each partner engages deeply with technical and ethical dimensions of investments. Risk Club dinner series: intimate gatherings debating key civilizational risks. Climbing Hard AI Peaks conferences: 100-person convenings of founders, builders, operators working on AI's hardest frontiers. Philosophy: "fluent in weirdness and volatility". Portfolio Quality Scale of outcomes: Multiple 10x+ exits (Privy/Stripe acquisition, Filecoin, IonQ, Groq). $1B+ in follow-on capital raised by portfolio in 2025. 76% gross IRR and 3.4× DPI on debut fund. 50+ portfolio companies across computation, defense, biotech, crypto, and physics.

Add BlueYard Capital to your investor list

Sign up free to save investors, see partner contacts, and track your raise.

Sign up